Ceftamart T 281.25mg Injection
Marketer
Martand Life Care Pvt. Ltd.
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ceftamart T 281.25mg Injection
Ceftamart T 281.25mg Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thus curbing infection spread. Administration must be overseen by a healthcare provider; adhere strictly to the prescribed dosage schedule. Complete the full treatment course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects promptly to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor about all current medications before starting this treatment. Pregnant or lactating individuals should consult their physician prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't impair driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, a balanced diet, and hydration support faster recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment response.
Primary Ingredients of Ceftamart T 281.25mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Ceftamart T 281.25mg Injection
Infections caused by bacteria
Major Benefits of Ceftamart T 281.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Ceftamart T 281.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftamart T 281.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Ceftamart T 281.25mg Injection works:
Ceftamart T 281.25mg Injection unites Ceftriaxone, a crucial antibiotic, with Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactum counters bacterial resistance, thereby boosting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Ceftamart T 281.25mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftamart T (281.25mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent harm to offspring; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Ceftamart T 281.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Ceftamart T 281.25mg Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on Ceftamart T 281.25mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Ceftamart T 281.25mg Injection cautiously, potentially requiring a modified dosage. Consult a physician for guidance. Dosage alteration for Ceftamart T 281.25mg Injection is unnecessary for individuals with mild to moderate liver dysfunction.
What if you forget to take Ceftamart T 281.25mg Injection :
Omitting a scheduled dose of Ceftamart T 281.25mg Injection necessitates contacting your physician.
Facts to Know About Ceftamart T 281.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |




